Stockscreener 앱 받기
3.06
1.66%
0.05
시간 외 거래:
3.06
전일 마감가:
$3.01
열려 있는:
$3.02
하루 거래량:
275.01K
Relative Volume:
1.77
시가총액:
$205.20M
수익:
-
순이익/손실:
$-64.20M
주가수익비율:
-
EPS:
-
순현금흐름:
$57,000
1주 성능:
-24.63%
1개월 성능:
-39.04%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$3.00
$3.22
1주일 범위
$3.00
$4.11
52주 변동 폭
$3.00
$5.47
Climb Bio Inc Stock (CLYM) Company Profile
명칭
Climb Bio Inc
전화
1-866-857-2596
주소
20 WILLIAM STREET, WELLESLEY HILLS
CLYM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| CLYM | 3.06 | 205.20M | 0 | -64.20M | 57,000 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Climb Bio Inc 주식(CLYM)의 최신 뉴스
Are Wall Street Analysts Predicting KKR Stock Will Climb or Sink? - MSN
Deep Track Capital, LP Reduces Stake in Climb Bio Inc - GuruFocus.com
Sri Lankan Stocks Climb, Information Technology Leads The Way - Finimize
Climb Bio Inc. Shifts Focus to Immune-Mediated Diseases - TipRanks
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire
iBio Reports Fiscal First Quarter 2025 Financial Results - The Manila Times
Climb Bio Secures FDA Clearance for SLE Drug Trial, Reports $217.9M Cash Position | CLYM Stock News - StockTitan
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board - GlobeNewswire
Climb Bio Appoints Biotech Veteran Douglas Williams as Board Chair, Strengthens Leadership | CLYM Stock News - StockTitan
Sales climb for EcoSynthetix Inc. in Q3 - Pulp & Paper Canada
Climb Bio to Present at Upcoming Investor Conferences - GlobeNewswire
Nasdaq Futures Climb on Upbeat Alphabet Results, U.S. GDP Data and More Big Tech Earnings on Tap - MSN
Humic Acid Market Set to Climb to USD 1.63 Billion by 2030 - openPR
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN
Tevogen Bio (TVGN) Sees Major Stock Surge After Key AI Move - Stocks Telegraph
Interpublic Group Of Cos., Inc. (IPG): Worth A Small Bite At $32.03 - Stocks Register
Why Lamb Weston Stock Was Climbing Today - Yahoo Finance
Big Bank Stocks Climb. 3 Stocks to Consider Adding to Your Portfolio. - Yahoo Finance
Merck & Co’s Clesrovimab Has Beyfortus Hill To Climb In RSV - Citeline News & Insights
Treasury Yields Climb as Strong Data Sow Doubt on Fed Rate Cuts - Yahoo Finance
Mortgage Demand Sees Sharpest Weekly Drop Since April 2020 As Rates Climb Above 6.5% - Yahoo Finance
Korean growth stocks climb after rate cut - 코리아타임스
Vale Achieves Six-Year High in Iron Ore Output, Copper and Nickel Production Also Climb - Yahoo Finance
European Wax Center Continues to Climb in Franchise Times' Top 400 Ranking - Yahoo Finance
US Mortgage Rates Climb to 6.52%, Highest Since Early August - Yahoo Finance
What You Need to Know Ahead of Bio-Techne's Earnings Release - TradingView
Stocks of B. Riley Financial Inc (RILY) are poised to climb above their peers - SETE News
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event - The Manila Times
‘Retirement super pot’ holders pay themselves around £3m each in a year - Yahoo Finance UK
Climb Bio to present kidney disease treatment study By Investing.com - Investing.com Australia
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024 - GlobeNewswire
Climb Bio to present kidney disease treatment study - Investing.com India
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology - The Bakersfield Californian
A stock that deserves closer examination: Climb Bio Inc. (CLYM) - US Post News
Climb Global (CLMB) Surged on Strong Results - Yahoo Finance
Quarterly IPOs Climb Back Above $1bn - Scrip
US 30-Year Mortgage Rate Climbs by Most in More Than a Year - Yahoo Finance
Climb Global (CLMB) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance
FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77% - Baystreet.ca
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - ForexTV.com
Climb Bio to Present at William Blair’s Upcoming Conference - GlobeNewswire
Climb Bio to Present at William Blair's Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - The Manila Times
Intumescent Coatings Market Size to Climb to USD 2.4 - GlobeNewswire
Intumescent Coatings Market Size to Climb to USD 2.4 billion by 2034 with a 7.4% CAGR, Supported by Steel Fabrication Fireproofing Demand | States Transparency Market Research, Inc. - Yahoo Finance
First Merchants Corporation to Report Third Quarter 2024 Financial Results, Host Conference Call and Webcast - The Manila Times
Climb Bio to Host Virtual Investor Event on October 15, 2024 - GlobeNewswire
Eliem Therapeutics rebrands to Climb Bio, shifts focus to immune diseases By Investing.com - Investing.com South Africa
Eliem Therapeutics rebrands to Climb Bio, shifts focus to immune diseases - Investing.com
Eliem Therapeutics Changes Name to Climb Bio - Yahoo Finance
Climb Bio Inc (CLYM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):